Post Content Previous Post Sundaram Finance Q4 Results: Revenue up 5%, profit aided by no exceptional loss; ₹21 dividend declared Next Post Lupin signs licensing deal with SteinCares for biosimilar ranibizumab in Latin America Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
